Literature DB >> 25060420

Treatment outcome in carpal tunnel syndrome: does distribution of sensory symptoms matter?

Franka Claes1, Kristel M Kasius2, Jan Meulstee3, J André Grotenhuis4, Wim I M Verhagen3.   

Abstract

BACKGROUND: Patients with complaints of carpal tunnel syndrome (CTS) with signs and symptoms not exclusively confined to the median nerve territory, but otherwise fulfilling the clinical criteria may erroneously be withheld from therapy.
METHODS: One hundred and twenty one patients who fulfilled the clinical criteria for the diagnosis of CTS with signs and symptoms restricted to the median nerve territory (group A) and 91 patients without this restriction (group B) were included in a prospective cohort study. All patients fulfilled electrodiagnostic criteria of CTS. Outcome was determined after 7 to 9 months by means of Symptom Severity Score (SSS) and Functional Status Score (FSS) according to Levine and a patient satisfaction questionnaire.
RESULTS: Response rates were 81.8% (group A) and 82.4% (group B). All patients in group B had sensory symptoms involving digit 5. There were no significant differences in improvement of SSS, FSS and patient satisfaction scores between groups after treatment.
CONCLUSION: CTS patients with characteristic sensory signs and symptoms not exclusively restricted to the median nerve innervated area should be treated in the same manner as patients with CTS symptoms restricted to the median nerve innervated area and should therefore not be withheld from surgical treatment.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Carpal tunnel syndrome; Classic; Extramedian; Non-classic; Outcome; Sensory

Mesh:

Year:  2014        PMID: 25060420     DOI: 10.1016/j.jns.2014.06.044

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

1.  Treatment outcome in patients with clinically defined carpal tunnel syndrome but normal electrodiagnostic test results: a randomized controlled trial.

Authors:  Floriaan G C M De Kleermaeker; Jan Meulstee; Franka Claes; Kristel M Kasius; Wim I M Verhagen
Journal:  J Neurol       Date:  2017-10-09       Impact factor: 4.849

2.  Efficacy of Keyhole Approach to Carpal Tunnel Syndrome under Ambulatory Strategy.

Authors:  Rodrigo Ramos-Zúñiga; César J García-Mercado; Iván Segura-Durán; Luis A Zepeda-Gutiérrez
Journal:  Neurol Res Int       Date:  2017-04-06

Review 3.  Nerve conduction studies and EMG in carpal tunnel syndrome: Do they add value?

Authors:  Masahiro Sonoo; Daniel L Menkes; Jeremy D P Bland; David Burke
Journal:  Clin Neurophysiol Pract       Date:  2018-04-05

4.  Diagnosis Accuracy of Carpal Tunnel Syndrome in Diabetic Neuropathy.

Authors:  Nicu Cătălin Drăghici; Maria Magdalena Tămaș; Daniel Corneliu Leucuța; Tudor Dimitrie Lupescu; Ștefan Strilciuc; Simona Rednic; Dafin Fior Mureșanu
Journal:  Medicina (Kaunas)       Date:  2020-06-05       Impact factor: 2.430

5.  Validation of the Dutch Version of the Boston Carpal Tunnel Questionnaire.

Authors:  Floriaan G C M De Kleermaeker; Mark Levels; Wim I M Verhagen; Jan Meulstee
Journal:  Front Neurol       Date:  2019-11-07       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.